N-METHYL-D-ASPARTATE (NMDA)
Overview
Namzaric is a prescription drug approved by the Food and Drug Administration (FDA) to treat moderate to severe cases of Alzheimer’s disease.
Namzaric is a combination drug composed of the drugs Memantine, the active ingredient in Namenda, and Donepezil, the active ingredient in Aricept. Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist. Memantine is believed to work by regulating the amount of glutamate, a neurotransmitter, in the brain. Donepezil is a cholinesterase inhibitor. Donepezil is believed to work by slowing the breakdown of a neurotransmitter in the brain.... read more
We never share your personal information with anyone.